These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Yoles E; Schwartz M Exp Neurol; 1998 Sep; 153(1):1-7. PubMed ID: 9743562 [TBL] [Abstract][Full Text] [Related]
3. The selective 5-HT(1A) receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats. Kline AE; Yu J; Horváth E; Marion DW; Dixon CE Neuroscience; 2001; 106(3):547-55. PubMed ID: 11591455 [TBL] [Abstract][Full Text] [Related]
4. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Yoles E; Wheeler LA; Schwartz M Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):65-73. PubMed ID: 9888428 [TBL] [Abstract][Full Text] [Related]
5. Large cortical lesions produce enduring forelimb placing deficits in un-treated rats and treatment with NMDA antagonists or anti-oxidant drugs induces behavioral recovery. Hoane MR; Barbay S; Barth TM Brain Res Bull; 2000 Sep; 53(2):175-86. PubMed ID: 11044594 [TBL] [Abstract][Full Text] [Related]
7. Optic nerve degeneration and potential neuroprotection: implications for glaucoma. Schwartz M; Yoles E Eur J Ophthalmol; 1999; 9 Suppl 1():S9-11. PubMed ID: 10230599 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of 4-(Phenylsulfanyl)butan-2-one on optic nerve crush model in rats. Chien JY; Sheu JH; Wen ZH; Tsai RK; Huang SP Exp Eye Res; 2016 Feb; 143():148-57. PubMed ID: 26472213 [TBL] [Abstract][Full Text] [Related]
9. Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats. Huang TL; Chang CH; Lin KH; Sheu MM; Tsai RK Exp Eye Res; 2011 Feb; 92(2):112-9. PubMed ID: 21185832 [TBL] [Abstract][Full Text] [Related]
10. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof]. Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678 [TBL] [Abstract][Full Text] [Related]
11. Morphological and functional analysis of an incomplete CNS fiber tract lesion: graded crush of the rat optic nerve. Klöcker N; Zerfowski M; Gellrich NC; Bähr M J Neurosci Methods; 2001 Sep; 110(1-2):147-53. PubMed ID: 11564535 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats. Rao VL; Dogan A; Todd KG; Bowen KK; Dempsey RJ Brain Res; 2001 Aug; 911(1):96-100. PubMed ID: 11489449 [TBL] [Abstract][Full Text] [Related]
13. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Brandt C; Potschka H; Löscher W; Ebert U Neuroscience; 2003; 118(3):727-40. PubMed ID: 12710980 [TBL] [Abstract][Full Text] [Related]
14. Brain neuronal degeneration caused by episodic alcohol intoxication in rats: effects of nimodipine, 6,7-dinitro-quinoxaline-2,3-dione, and MK-801. Corso TD; Mostafa HM; Collins MA; Neafsey EJ Alcohol Clin Exp Res; 1998 Feb; 22(1):217-24. PubMed ID: 9514310 [TBL] [Abstract][Full Text] [Related]
15. Dexanabinol (HU-211) has a beneficial effect on axonal sprouting and survival after rat optic nerve crush injury. Zalish M; Lavie V Vision Res; 2003 Feb; 43(3):237-42. PubMed ID: 12535983 [TBL] [Abstract][Full Text] [Related]
16. Secondary degeneration of the optic nerve following partial transection: the benefits of lomerizine. Fitzgerald M; Bartlett CA; Evill L; Rodger J; Harvey AR; Dunlop SA Exp Neurol; 2009 Mar; 216(1):219-30. PubMed ID: 19118550 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats. Tsai RK; Chang CH; Wang HZ Exp Eye Res; 2008 Sep; 87(3):242-50. PubMed ID: 18602391 [TBL] [Abstract][Full Text] [Related]
19. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective. Priestley T; Marshall GR; Hill RG; Kemp JA Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395 [TBL] [Abstract][Full Text] [Related]
20. Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats. Suzuki Y; Takagi Y; Nakamura R; Hashimoto K; Umemura K Brain Res; 2003 Feb; 964(1):116-20. PubMed ID: 12573519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]